Access Support News

News

GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine

06/10/2024

Grace Taylor, MS, MA

General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.

General Electric (GE) HealthCare...

06/10/2024

Journal of Clinical Pathways

News

US Cancer Centers Still Struggling with Chemotherapy Shortages, NCCN’s Recent Survey Reveals

11/04/2023

Brandon Twyford

Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.

Results from NCCN's recent...

11/04/2023

Journal of Clinical Pathways

News

Tracking Cost of Care Discussions Between Physicians and Patients with NSCLC and Melanoma

10/30/2023

Grace Taylor

Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.

Robin Yabroff, PhD, MBA, and...

10/30/2023

Journal of Clinical Pathways

News

Do Medically Integrated Pharmacies Reduce the Abandonment Rate of Oral Anticancer Medications?

10/30/2023

Emry Lloyd

Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.

Dr Doshi and colleagues measured...

10/30/2023

Journal of Clinical Pathways

News

The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs

10/28/2023

Grace Taylor

Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.

Puneeth Indurlal, MD, MS, and...

10/28/2023

Journal of Clinical Pathways

News

The Impact of Dosing Approaches for Lenalidomide on Total Cost of Care

10/27/2023

Grace Taylor

Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.

Puneeth Indurlal, MD, MS, The US...

10/27/2023

Journal of Clinical Pathways

News

Access to Pediatric Palliative Care Assessed in Resource-Constrained Communities

10/27/2023

Emry Lloyd

Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.

Dr Houston and colleagues...

10/27/2023

Journal of Clinical Pathways

News

Rollback of Prescription Delivery Flexibilities Poses Challenges for At-Risk Cancer Patients

10/27/2023

Brandon Twyford

Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.

Research presented at the 2023...

10/27/2023

Journal of Clinical Pathways

News

The Influence of End-of-Life Care Costs on Episodic Value-Based Care Models

10/26/2023

Emry Lloyd

In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.

In this study, Gunjan Sharma,...

10/26/2023

Journal of Clinical Pathways

News

Virtual Consult Pilot Successfully Implemented in Integrated Health System

10/26/2023

Brandon Twyford

An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.

An innovative virtual consult...

10/26/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Access Support News

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products